Activity of nsp14 Exonuclease from SARS-CoV-2 towards RNAs with Modified 3'-Termini.

RNA oligonucleotides antiviral drugs coronaviruses exonucleases nsp10 nsp14 nucleoside inhibitors replication proofreading

Journal

Doklady. Biochemistry and biophysics
ISSN: 1608-3091
Titre abrégé: Dokl Biochem Biophys
Pays: United States
ID NLM: 101126895

Informations de publication

Date de publication:
Apr 2023
Historique:
received: 25 11 2022
accepted: 09 12 2022
revised: 05 12 2022
medline: 22 6 2023
pubmed: 21 6 2023
entrez: 20 6 2023
Statut: ppublish

Résumé

The COVID-19 pandemic has shown the urgent need for new treatments for coronavirus infections. Nucleoside analogs were successfully used to inhibit replication of some viruses through the incorporation into the growing DNA or RNA chain. However, the replicative machinery of coronaviruses contains nsp14, a non-structural protein with a 3'→5'-exonuclease activity that removes misincorporated and modified nucleotides from the 3' end of the growing RNA chain. Here, we studied the efficiency of hydrolysis of RNA containing various modifications in the 3'-terminal region by SARS-CoV-2 nsp14 exonuclease and its complex with the auxiliary protein nsp10. Single-stranded RNA was a preferable substrate compared to double-stranded RNA, which is consistent with the model of transfer of the substrate strand to the exonuclease active site, which was proposed on the basis of structural analysis. Modifications of the phosphodiester bond between the penultimate and last nucleotides had the greatest effect on nsp14 activity.

Identifiants

pubmed: 37340295
doi: 10.1134/S1607672923700102
pii: 10.1134/S1607672923700102
doi:

Substances chimiques

Exonucleases EC 3.1.-
RNA, Viral 0
Nucleotides 0
Antiviral Agents 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

65-69

Informations de copyright

© 2023. Pleiades Publishing, Ltd.

Références

Su, S., Wong, G., Shi, W., et al., Trends Microbiol., 2016, vol. 24, no. 6, pp. 490–502.
doi: 10.1016/j.tim.2016.03.003 pubmed: 27012512 pmcid: 7125511
Jayk Bernal, A., Gomes da Silva, M.M., Musun-gaie, D.B., et al., N. Engl. J. Med., 2022, vol. 386, no. 6, pp. 509–520.
doi: 10.1056/NEJMoa2116044 pubmed: 34914868
Bravo, J.P.K., Dangerfield, T.L., Taylor, D.W., and Johnson, K.A., Mol. Cell, 2021, vol. 81, no. 7, pp. 1548–1552.
doi: 10.1016/j.molcel.2021.01.035 pubmed: 33631104 pmcid: 7843106
Shannon, A., Selisko, B., Le, N.-T.-T., et al., Nat. Commun., 2020, vol. 11, p. 4682.
doi: 10.1038/s41467-020-18463-z pubmed: 32943628 pmcid: 7499305
Ferron, F., Subissi, L., Silveira, De., Morais, A.T., et al., Proc. Natl. Acad. Sci. U. S. A., 2018, vol. 115, no. 2, pp. E162–E171.
doi: 10.1073/pnas.1718806115 pubmed: 29279395
Bouvet, M., Imbert, I., Subissi, L., et al., Proc. Natl. Acad. Sci. U. S. A., 2012, vol. 109, no. 24, pp. 9372–9377.
doi: 10.1073/pnas.1201130109 pubmed: 22635272 pmcid: 3386072
Ma, Y., Wu, L., Shaw, N., et al., Proc. Natl. Acad. Sci. U. S. A., 2015, vol. 112, no. 30, pp. 9436–9441.
doi: 10.1073/pnas.1508686112 pubmed: 26159422 pmcid: 4522806
Zuo, Y. and Deutscher, M.P., Nucleic Acids Res., 2001, vol. 29, no. 5, pp. 1017–1026.
doi: 10.1093/nar/29.5.1017 pubmed: 11222749 pmcid: 56904
Liu, C., Shi, W., Becker, S.T., et al., Science, 2021, vol. 373, no. 6559, pp. 1142–1146.
doi: 10.1126/science.abi9310 pubmed: 34315827 pmcid: 9836006
Chelobanov, B.P., Burakova, E.A., Prokhorova, D.V., et al., Russ. J. Bioorg. Chem., 2017, vol. 43, no. 6, pp. 664-668.
doi: 10.1134/S1068162017060024
Miroshnichenko, S.K., Patutina, O.A., Burakova, E.A., et al., Proc. Natl. Acad. Sci. U. S. A., 2019, vol. 116, no. 4, pp. 1229–1234.
doi: 10.1073/pnas.1813376116 pubmed: 30622178 pmcid: 6347720
Minskaia, E., Hertzig, T., Gorbalenya, A.E., et al., Proc. Natl. Acad. Sci. U. S. A., 2006, vol. 103, no. 13, pp. 5108–5113.
doi: 10.1073/pnas.0508200103 pubmed: 16549795 pmcid: 1458802
Ogando, N.S., Zevenhoven-Dobbe, J.C., van der Meer, Y., et al., J. Virol., 2020, vol. 94, no. 23.
Yan, L., Yang, Y., Li, M., et al., Cell, 2021, vol. 184, no. 13, pp. 3474–3485.
doi: 10.1016/j.cell.2021.05.033 pubmed: 34143953 pmcid: 8142856

Auteurs

S K Yuyukina (SK)

Novosibirsk State University, Novosibirsk, Russia. sonyayuyukina@gmail.com.
Institute of Chemical Biology and Fundamental Medicine, Siberian Branch, Russian Academy of Sciences, Novosibirsk, Russia. sonyayuyukina@gmail.com.

A E Barmatov (AE)

Institute of Chemical Biology and Fundamental Medicine, Siberian Branch, Russian Academy of Sciences, Novosibirsk, Russia.

S N Bizyaev (SN)

Novosibirsk State University, Novosibirsk, Russia.
Institute of Cytology and Genetics, Siberian Branch, Russian Academy of Sciences, Novosibirsk, Russia.
Vorozhtsov Novosibirsk Institute of Organic Chemistry, Siberian Branch, Russian Academy of Sciences, Novosibirsk, Russia.

D A Stetsenko (DA)

Novosibirsk State University, Novosibirsk, Russia.
Institute of Cytology and Genetics, Siberian Branch, Russian Academy of Sciences, Novosibirsk, Russia.

O V Sergeeva (OV)

Skolkovo Institute of Science and Technology, Moscow, Russia.

T S Zatsepin (TS)

Skolkovo Institute of Science and Technology, Moscow, Russia.
Department of Chemistry, Moscow State University, Moscow, Russia.

D O Zharkov (DO)

Novosibirsk State University, Novosibirsk, Russia. dzharkov@niboch.nsc.ru.
Institute of Chemical Biology and Fundamental Medicine, Siberian Branch, Russian Academy of Sciences, Novosibirsk, Russia. dzharkov@niboch.nsc.ru.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH